Asia-Pacific Antifungal Drugs Market: By Product Type (Azoles, Allylamines, Echinocandins, Polyenes and Others), By Dosage Forms (Solutions, Tablets & Capsules, Ointments & Creams, Powders, and Others), By Application (Aspergillosis, Candidiasis, Dermatophytosis, and Others) By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, and Drug Stores), and Country (Japan, China, India, Australia & New Zealand, ASEAN, South Korea, and Rest of Asia-Pacific) - Market Estimation, Dynamics, Country Share, Trends, Competitor Analysis 2012-2016 and Forecast 2017-2023

October 2017 | 78 pages | ID: A6C652B52ACEN
Precision Business Insights (PBI)

Abstracts

Asia-Pacific Antifungal Drugs Market Report Description:

Asia-Pacific antifungal drugs market report gives comprehensive outlook on antifungal drugs prescription pattern across the region with special emphasis on key countries such as Japan, China, India, Australia & New Zealand, Indonesia, Thailand, Vietnam, Philippines, Malaysia, and South Korea. The report on antifungal drugs market gives historical, current, and future market sizes (US$ Mn) on the basis of product type, application, dosage from, and country. This report presents antifungal drugs market dynamics elaborately to identify the current market trends & drivers, future opportunities and possible challenges to the key stakeholders operating in the market. In addition, antifungal drugs market report includes the competition analysis with vividly illustrated the competition dashboard to assess the market competition. Moreover, PBI analyzed antifungal drugs market to better equip clients with possible investment opportunities across the regions (Country Investment Hot-Spots) and market unmet needs. Key stakeholders of the Asia-Pacific antifungal drugs market report include raw material suppliers, manufacturers, marketers, hospitals, physician offices, policy makers, and healthcare service providers, who are engaged in usage and advocacy of antifungal drugs.

Asia-Pacific Antifungal drugs Market:

Asia-Pacific antifungal drugs market was valued around US$ 2,500 Mn in 2016 and poised to grow around 4% CAGR over 2017-2023.

COMPETITION ASSESSMENT

Key players profiles in the Asia-Pacific antifungal drugs market include:

• Astellas Pharma, Inc. (Japan)
• Bayer AG (Germany)
• Enzon Pharmaceuticals, Inc. (U.S.)
• GlaxoSmithKline plc. (U.K.)
• Merck & Co., Inc. (U.S.)
• Novartis AG (Switzerland)
• Pfizer, Inc. (U.S.)
• Sanofi (France)

Players in the Asia-Pacific antifungal drugs market are entering into partnerships and collaborations to garner larger market share

KEY FEATURES OF THE REPORT:

• The report provides granular level information about the market size, regional market share, historic market (2012-2016) and forecast (2017-2023)
• The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
• The Report Outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
• The report tracks recent innovations, key developments and startup’s details that are actively working in the market
• The report provides plethora of information about market entry strategies, regulatory framework and reimbursement scenario
• The report analyses the impact of socio-political environment through PESTLE Analysis and competition through Porter’s Five Force Analysis in addition to recent technology advancements and innovations in the market

DETAILED SEGMENTATION

By Product Type

• Azoles
• Allylamines
• Echinocandins
• Polyenes
• Others

By Dosage Forms

• Solutions
• Tablets & Capsules
• Ointments & Creams
• Powders
• Others

By Application

• Aspergillosis
• Candidiasis
• Dermatophytosis
• Others

By Distribution Channel

• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies
• Drug Stores

Geography

• Asia-Pacific
• Japan
• China
• India
• Australia & New Zealand
• ASEAN (Includes Indonesia, Thailand, Vietnam, Philippines, Malaysia, and Others)
• South Korea
• Rest of Asia-Pacific

Contents

1. EXECUTIVE SUMMARY

2. ASIA-PACIFIC ANTIFUNGAL DRUGS MARKET INTRODUCTION

2.1. Asia-Pacific Antifungal Drugs Market – Taxonomy
2.2. Asia-Pacific Antifungal Drugs Market –Definitions
  2.2.1. Product Type
  2.2.2. Dosage Forms
  2.2.3. Application
  2.2.4. Distribution Channel

3. ASIA-PACIFIC ANTIFUNGAL DRUGS MARKET DYNAMICS

3.1. Drivers
3.2. Restraints
3.3. Opportunities/Unmet Needs of the Market
3.4. Trends
3.5. Asia-Pacific Antifungal Drugs Market Dynamics – Factors Impact Analysis
3.6. Asia-Pacific Antifungal Drugs Market – Regulations
  3.6.1. Japan
  3.6.2. China
3.7. Asia-Pacific Antifungal Drugs Market – Product Innovations

4. ASIA-PACIFIC ANTIFUNGAL DRUGS MARKET ANALYSIS, 2012 - 2016 AND FORECAST, 2017 – 2023

4.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
4.2. Year-over-Year (Y-o-Y) Growth Analysis (%)
4.3. Market Oppurtunity Analysis

5. ASIA-PACIFIC ANTIFUNGAL DRUGS MARKET, BY PRODUCT TYPE, 2012 - 2016 AND FORECAST, 2017 - 2023

5.1. Azoles
  5.1.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  5.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis
  5.1.3. Market Opportunity Analysis
5.2. Allylamines
  5.2.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  5.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis
  5.2.3. Market Opportunity Analysis
5.3. Echinocandins
  5.3.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  5.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis
  5.3.3. Market Opportunity Analysis
5.4. Polyenes
  5.4.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  5.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis
  5.4.3. Market Opportunity Analysis
5.5. Others
  5.5.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  5.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis
  5.5.3. Market Opportunity Analysis

6. ASIA-PACIFIC ANTIFUNGAL DRUGS MARKET FORECAST, BY DOSAGE FORMS, 2012 - 2016 AND FORECAST, 2017 - 2023

6.1. Solutions
  6.1.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  6.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis
  6.1.3. Market Opportunity Analysis
6.2. Tablets & Capsules
  6.2.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  6.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis
  6.2.3. Market Opportunity Analysis
6.3. Ointments & Creams
  6.3.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  6.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis
  6.3.3. Market Opportunity Analysis
6.4. Powders
  6.4.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  6.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis
  6.4.3. Market Opportunity Analysis
6.5. Others
  6.5.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  6.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis
  6.5.3. Market Opportunity Analysis

7. ASIA-PACIFIC ANTIFUNGAL DRUGS MARKET FORECAST, BY APPLICATION, 2012 - 2016 AND FORECAST, 2017 - 2023

7.1. Aspergillosis
  7.1.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  7.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis
  7.1.3. Market Opportunity Analysis
7.2. Candidiasis
  7.2.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  7.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis
  7.2.3. Market Opportunity Analysis
7.3. Dermatophytosis
  7.3.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  7.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis
  7.3.3. Market Opportunity Analysis
7.4. Others
  7.4.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  7.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis
  7.4.3. Market Opportunity Analysis

8. ASIA-PACIFIC ANTIFUNGAL DRUGS MARKET FORECAST, BY DISTRIBUTION CHANNEL, 2012 - 2016 AND FORECAST, 2017 - 2023

8.1. Hospital Pharmacies
  8.1.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  8.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis
  8.1.3. Market Opportunity Analysis
8.2. Retail Pharmacies
  8.2.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  8.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis
  8.2.3. Market Opportunity Analysis
8.3. Online Pharmacies
  8.3.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  8.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis
  8.3.3. Market Opportunity Analysis
8.4. Drug Stores
  8.4.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  8.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis
  8.4.3. Market Opportunity Analysis

9. ASIA-PACIFIC ANTIFUNGAL DRUGS MARKET FORECAST, BY COUNTRY, 2012 - 2016 AND FORECAST, 2017 - 2023

9.1. China
  9.1.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  9.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis
  9.1.3. Market Opportunity Analysis
9.2. Japan
  9.2.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  9.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis
  9.2.3. Market Opportunity Analysis
9.3. India
  9.3.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  9.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis
  9.3.3. Market Opportunity Analysis
9.4. ASEAN
  9.4.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  9.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis
  9.4.3. Market Opportunity Analysis
9.5. Australia and New Zealand
  9.5.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  9.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis
  9.5.3. Market Opportunity Analysis
9.6. South Korea
  9.6.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  9.6.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis
  9.6.3. Market Opportunity Analysis
9.7. Other
  9.7.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  9.7.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis
  9.7.3. Market Opportunity Analysis
9.8. Asia-Pacific Antifungal Drugs Market - Opportunity Analysis Index, By Product Type, Dosage Forms, Application, and Region, 2017 – 2023

10. CHINA ANTI-FUNGAL DRUGS MARKET ANALYSIS, 2012 - 2016 AND FORECAST, 2017 - 2023

  10.1.1. Product Type Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
    10.1.1.1. Azoles
    10.1.1.2. Allylamines
    10.1.1.3. Echinocandins
    10.1.1.4. Polyenes
    10.1.1.5. Others
  10.1.2. Dosage Forms Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
    10.1.2.1. Solutions
    10.1.2.2. Tablets & Capsules
    10.1.2.3. Ointments & Creams
    10.1.2.4. Powders
    10.1.2.5. Others
  10.1.3. Application Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
    10.1.3.1. Aspergillosis
    10.1.3.2. Candidiasis
    10.1.3.3. Dermatophytosis
    10.1.3.4. Others
  10.1.4. Distribution Channel Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
    10.1.4.1. Hospital Pharmacies
    10.1.4.2. Retail Pharmacies
    10.1.4.3. Online Pharmacies
    10.1.4.4. Drug Stores
  10.1.5. Asia-Pacific Anti-Fungal Drugs Market - Opportunity Analysis Index, By Product Type, Dosage Forms, Application, and Country, 2017 – 2023
  10.1.6. Asia-Pacific Anti-Fungal Drugs Market Dynamics – Trends

11. JAPAN ANTI-FUNGAL DRUGS MARKET ANALYSIS, 2012 - 2016 AND FORECAST, 2017 – 2023

12. INDIA ANTI-FUNGAL DRUGS MARKET ANALYSIS, 2012 - 2016 AND FORECAST, 2017 – 2023

13. ASEAN ANTI-FUNGAL DRUGS MARKET ANALYSIS, 2012 - 2016 AND FORECAST, 2017 – 2023

14. AUSTRALIA AND NEW ZEALAND ANTI-FUNGAL DRUGS MARKET ANALYSIS, 2012 - 2016 AND FORECAST, 2017 – 2023

15. OTHERS ANTI-FUNGAL DRUGS MARKET ANALYSIS, 2012 - 2016 AND FORECAST, 2017 – 2023

16. COMPETITION LANDSCAPE

16.1. Strategic Dashboard of Top Market Players
16.2. Company Profiles (Introduction, Financial Analysis, Product & Service Offerings, Key Developments, Strategies, and SWOT Analysis)
  16.2.1. Astellas Pharma, Inc. (Japan)
  16.2.2. Bayer AG (Germany)
  16.2.3. Enzon Pharmaceuticals, Inc. (U.S.)
  16.2.4. GlaxoSmithKline plc. (U.K.)
  16.2.5. Merck & Co., Inc. (U.S.)
  16.2.6. Novartis AG (Switzerland)
  16.2.7. Pfizer, Inc. (U.S.)
  16.2.8. Sanofi (France)

17. RESEARCH METHODOLOGY

18. KEY ASSUMPTIONS AND ACRONYMS